MS Society of Canada Commits $1m for CCSVI Clinical Trial
The funding will be set aside so that an immediate infusion of funding will be available when such a trial is developed and approved.
The MS Society of Canada hopes to work with the provinces and the federal government to secure all of the funding for a therapeutic clinical trial. At the recent health ministers' meeting in Newfoundland, provinces and territories collectively stated that the issue of CCSVI is a top priority.
In summer 2010, the Federal Minister of Health accepted the Canadian Institutes of Health Research's recommendation to create an expert scientific working group to monitor the results of the studies already underway.
The Canadian Institutes of Health experts will analyze the evidence about the definition and nature of venous blockages and their relationship with MS, since this information will be central to obtaining ethical approval to enrol participants in a trial.
Yves Savoie, president and CEO of the MS Society, said: “We want to hit the ground running when a therapeutic trial is warranted and approved. Ensuring funds are available to support a Canadian trial will accelerate our ability to get definitive answers to the questions people touched by MS urgently seek.
“We applaud the spirit of cooperation that the federal, provincial and territorial governments have shown in moving CCSVI to the forefront of country's health agenda. The MS Society of Canada is ready to play a central role in preparing for and funding a scientifically rigorous pan-Canadian therapeutic clinical trial to test CCSVI.”
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.